Effects of the Application of a Hyper-oxygenated Gel After Oral Surgery
Effects of the Application of a Hyper-oxygenated Gel After Extraction of Impacted Lower Third Molars: Randomized Controlled Study
Azienda Ospedaliera di Perugia
72 participants
Jul 1, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate whether the topical application of Novox® Drop on surgical wounds after the extraction of lower third molars can have a clinical advantage. The primary objective of the study is to evaluate the possible reduction of masseteric trismus (masticatory muscle spasm - primary outcome) and of post-operative pain and facial edema (swelling - secondary outcomes) after the extraction of impacted third molars compared to those who do not use it (placebo=glycerin-based gel).
Eligibility
Inclusion Criteria5
- good systemic and local health conditions of the patient;
- age between 18 and 35 years;
- understanding of the Italian language,
- indications for the extraction of impacted bilateral lower third molars (38 and 48) according to the criteria reported in the classifications of Winter and that of Pell and Gregory;
- the root of the impacted third molars is completely formed.
Exclusion Criteria11
- diabetes mellitus;
- systemic arterial hypertension;
- hyperthyroidism;
- osteoporosis;
- immunosuppressed;
- osteonecrosis of the jaws;
- pregnancy;
- patients with mandibular third molars in position C according to "the Pell \& Gregory Classification" on the radiological measurements (angles and positions) for which third molar extraction surgery is required.;
- local alterations such as pericoronitis, odontogenic cysts and tumors in relation to the third molars;
- allergies;
- ordinary use of analgesics or antibiotics by the patient.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Novox drop is a medical device (CE certified, class II b, non-invasive) based on oxygen-enriched olive oil (Excipients: Mint essential oil (2%), Stevia extract (1%)). Mechanism of action: facilitate the healing process by creating, thanks to the release of reactive oxygen species (ROS), a microenvironment favorable to the activation of the microcirculation and at the same time unfavorable to the proliferation of pathogens. Furthermore, it has a film-forming, protective, barrier and soothing action thanks to its oily nature.
The placebo consists of a viscous, colorless and transparent gel, based on glycerin (Conformity:FUI).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06458478